 | Biocon and Serum Institute come together with strategic alliance to increase vaccine access for developing countriesAs part of the deal, the BBL has offered 15% stake to SILS at a post money valuation of $4.9 billion in exchange for committed access to 100 million doses of vaccines per annul for 15 years. |
 | Booster dose ‘unethical’ now, may be needed later: Adar PoonawallaSerum Institute to ramp up production of Covishield to 200mn doses a month |
 | PM Modi, Mamata, Banerjee, Adar Poonawalla among Time Magazine's 100 'most influential people of 2021'Taliban co-founder Abdul Ghani Baradar has also made it to the list. The Time profile describes Baradar as a "quiet, secretive man who rarely gives public statements or interviews." |
| Hopeful of launching Covovax for adults in October this year, for children in Q1-2022: Serum CEOCovovax will be a two-dose vaccine and the price will be decided at the time of launch, he added. |
| Serum Institute CEO Adar Poonawalla sets aside Rs 10 crore to support students travelling abroadEarlier in July, he had lauded 16 European countries for recognising Covishield as an acceptable vaccine for entry. |
| Confident of getting EMA's approval in a month for Covishield: Adar PoonawallaHe also said the issue of vaccine passports should be on the basis of reciprocity between the countries. |
| Hope to resolve issues faced by Indians vaccinated with Covishield travelling to EU soon: PoonawallaI have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries, Poonawalla said in a tweet. |
 | 'A new milestone': Serum Institute begins Covovax production in Pune, jab likely from SeptemberEarlier, Novavax had said that its vaccine has an efficacy of 90.4% in preventing infection and 100% efficacy against moderate to severe disease. |
| Would provide security to SII CEO Adar Poonawalla if he asks: Maharashtra government to HCThe Union government has already provided `Y' category CRPF protection to Poonawalla. |
| Poonawalla thanks Biden, Jaishankar for policy change to boost vaccine productionConfident of the availability of COVID-19 vaccines in the US, the Biden administration has removed Defense Production Act priority ratings on AstraZeneca, Novavax and Sanofi vaccines. |
 | Will be able to manufacture, supply 10 crore Covishield doses in June: Serum Institute to CentreIndia is currently using made-in-India vaccines -- Covishield manufactured by SII and Covaxin of Bharat Biotech -- in its COVID-19 immunisation programme. |
 | HC seeks Uddhav government's reply on plea seeking Z-plus security for Adar PoonawallaThe petitioner will have to bear in mind while arguing this matter that "India has a good reputation and such proceedings will have an international impact", the HC said. |
 | Covishield vaccine supply for Maharashtra unlikely to start from May 20, state to approach Serum InstituteThe state government has some five lakh vials of Covishield and Covaxin, which is going to be used for completion of second dose as well as first dose of people in above 45 age group. |
 | Plea in Bombay HC seeks Z-plus security for Serum Institute CEO Adar Poonawalla, his familyThe plea requested the court to give order to Maharashtra government and Pune Police Commissioner to file an FIR in the matter based on the petitioner's complaint which he has already submitted. |
| Serum Institute CEO Adar Poonawalla to invest over USD 300 million in UK, may make inoculationsThe British Prime Minister's office said the USD 334 million project would include a sales office, 'clinical trials, research and development and possibly manufacturing of vaccines'. |
